(0.80%) 5 169.05 points
(0.37%) 38 820 points
(0.91%) 16 303 points
(0.77%) $78.71
(2.71%) $2.20
(1.08%) $2 333.50
(3.71%) $27.68
(0.06%) $965.85
(-0.06%) $0.928
(-0.46%) $10.82
(-0.17%) $0.796
(-0.12%) $91.35
4 days till quarter result
(bmo 2024-05-10)
Expected move: +/- 0.00%
-0.74% ¥ 5 380.00
Live Chart Being Loaded With Signals
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company provides products in the areas of healthcare, skincare, body warmer, and household...
Stats | |
---|---|
Volumen de hoy | 1.29M |
Volumen promedio | 3.00M |
Capitalización de mercado | 399.94B |
EPS | ¥0 ( 2024-02-08 ) |
Próxima fecha de ganancias | ( ¥54.40 ) 2024-05-10 |
Last Dividend | ¥39.00 ( 2023-06-29 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 20.08 |
ATR14 | ¥3.69 (0.07%) |
Volumen Correlación
Kobayashi Pharmaceutical Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Kobayashi Pharmaceutical Correlación - Moneda/Commodity
Kobayashi Pharmaceutical Finanzas
Annual | 2023 |
Ingresos: | ¥173.46B |
Beneficio Bruto: | ¥93.17B (53.72 %) |
EPS: | ¥268.16 |
FY | 2023 |
Ingresos: | ¥173.46B |
Beneficio Bruto: | ¥93.17B (53.72 %) |
EPS: | ¥268.16 |
FY | 2022 |
Ingresos: | ¥166.26B |
Beneficio Bruto: | ¥92.33B (55.53 %) |
EPS: | ¥259.61 |
FY | 2021 |
Ingresos: | ¥155.25B |
Beneficio Bruto: | ¥88.77B (57.18 %) |
EPS: | ¥187.94 |
Financial Reports:
No articles found.
Kobayashi Pharmaceutical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥52.00 (N/A) |
¥0 (N/A) |
¥39.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥1.667 | 2001-03-27 |
Last Dividend | ¥39.00 | 2023-06-29 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 41 | -- |
Total Paid Out | ¥957.83 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.48 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.23 | |
Div. Directional Score | 6.90 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
5703.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
4523.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3681.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
2975.T | Ex Dividend Knight | 2023-11-29 | Semi-Annually | 0 | 0.00% | |
1827.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
9790.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
8877.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8345.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7730.T | Ex Dividend Knight | 2023-08-30 | Semi-Annually | 0 | 0.00% | |
6904.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.117 | 1.500 | 7.65 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0760 | 1.200 | 7.47 | 8.96 | [0 - 0.3] |
returnOnEquityTTM | 0.0984 | 1.500 | -0.0179 | -0.0268 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.82 | 0.800 | 0.891 | 0.713 | [1 - 3] |
quickRatioTTM | 2.37 | 0.800 | 0.782 | 0.625 | [0.8 - 2.5] |
cashRatioTTM | 1.275 | 1.500 | 4.03 | 6.04 | [0.2 - 2] |
debtRatioTTM | 0.00369 | -1.500 | 9.94 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 921.00 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 161.45 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 161.45 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.00482 | -1.500 | 9.98 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.545 | 1.000 | 4.24 | 4.24 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.154 | 1.000 | 8.92 | 8.92 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 12.27 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.648 | 0.800 | 9.01 | 7.21 | [0.5 - 2] |
Total Score | 10.57 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 19.85 | 1.000 | 8.10 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0984 | 2.50 | -0.0115 | -0.0268 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 161.45 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.877 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 161.45 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0698 | 1.000 | -0.754 | 0 | [0.1 - 0.5] |
Total Score | 3.23 |
Kobayashi Pharmaceutical
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company provides products in the areas of healthcare, skincare, body warmer, and household. It also offers Ammeltz, a topical analgesic; Inochi no Haha, a women's health medicine; Shirt Coola, a summer cooling spray for cloths; Sarasaty lingerie soap; Bluelet Decoral, a toilet bowl cleaner and freshener; Nightmin Nasal Respiration Tape; Naishitol, a Chinese medicine; Eaude Muge, a medicated lotion for preventing acne; Itoyoji, a dental floss pick; BreathCare, an oral breath freshener capsule; Eybon, an eye wash; Netsusama sheet, a cooling gel sheet for forehead; and Sawaday, a toilet air freshener. Additionally, the company manufactures and sells pharmaceuticals, quasi-drugs, cosmetics, hygiene and paper products, health foods, and processed synthetic resin products; markets nutritional supplements and skin care products through sales promotional campaigns, such as advertising and direct mail; and sells skincare products, health foods, and other items through e-commerce channels. Further, it engages in transportation, real estate management, and advertising planning and production businesses. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico